Literature DB >> 24512576

Genetic analysis of GRIA2 and GRIA4 genes in migraine.

Claudia F Gasparini1, Heidi G Sutherland, Larisa M Haupt, Lyn R Griffiths.   

Abstract

BACKGROUND: Migraine is a brain disorder affecting ∼12% of the Caucasian population. Genes involved in neurological, vascular, and hormonal pathways have all been implicated in predisposing individuals to developing migraine. The migraineur presents with disabling head pain and varying symptoms of nausea, emesis, photophobia, phonophobia, and occasionally visual sensory disturbances. Biochemical and genetic studies have demonstrated dysfunction of neurotransmitters: serotonin, dopamine, and glutamate in migraine susceptibility. Glutamate mediates the transmission of excitatory signals in the mammalian central nervous system that affect normal brain function including cognition, memory and learning. The aim of this study was to investigate polymorphisms in the GRIA2 and GRIA4 genes, which encode subunits of the ionotropic AMPA receptor for association in an Australian Caucasian population.
METHODS: Genotypes for each polymorphism were determined using high resolution melt analysis and the RFLP method.
RESULTS: Statistical analysis showed no association between migraine and the GRIA2 and GRIA4 polymorphisms investigated.
CONCLUSIONS: Although the results of this study showed no significant association between the tested GRIA gene variants and migraine in our Australian Caucasian population further investigation of other components of the glutamatergic system may help to elucidate if there is a relationship between glutamatergic dysfunction and migraine.
© 2013 American Headache Society.

Entities:  

Keywords:  AMPA receptor; GRIA2; GRIA4; glutamate; migraine; migraine with aura; migraine without aura

Mesh:

Substances:

Year:  2013        PMID: 24512576     DOI: 10.1111/head.12234

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

Review 1.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

2.  Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress.

Authors:  Timea Aczél; Bettina Benczik; József Kun; Zsuzsanna Helyes; Bence Ágg; Tamás Körtési; Péter Urbán; Witold Bauer; Attila Gyenesei; Bernadett Tuka; János Tajti; Péter Ferdinandy; László Vécsei; Kata Bölcskei
Journal:  J Headache Pain       Date:  2022-09-02       Impact factor: 8.588

3.  Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology.

Authors:  Ti Li; Shupeng Guo; Meixi Lu; Fang Lu; Tianjiao Lu; Chunze Zheng
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

4.  Integrative Functional Genomic Analysis of Molecular Signatures and Mechanistic Pathways in the Cell Cycle Underlying Alzheimer's Disease.

Authors:  Zhike Zhou; Jun Bai; Shanshan Zhong; Rongwei Zhang; Kexin Kang; Xiaoqian Zhang; Ying Xu; Chuansheng Zhao; Mei Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-07-11       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.